AN OPEN-LABEL INTERNATIONAL PHASE III STUDY OF THE LONG-TERM SAFETY OF LIPROTAMASE FOR TREATMENT OF PANCREATIC INSUFFICIENCY IN CF

被引：0
|
作者：
Borowitz, D. [1 ]
Stevens, C. [2 ]
Fratazzi, C. [2 ]
Cohen, D. [2 ]
Campion, M. [2 ]
机构：
[1] SUNY Buffalo, Womens & Childrens Hosp, Dept Pediat, Buffalo, NY 14260 USA
[2] Alnara Pharmaceut Inc, Cambridge, MA USA
来源：
PEDIATRIC PULMONOLOGY | 2009年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
520
引用
收藏
页码：397 / 398
页数：2
相关论文
共 50 条
  • [31] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [32] Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy
    Shinnar, Shlomo
    Pellock, John M.
    Conry, Joan A.
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (01) : 3 - 9
  • [33] Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study
    Emre, Murat
    Poewe, Werner
    De Deyn, Peter Paul
    Barone, Paolo
    Kulisevsky, Jaime
    Pourcher, Emmanuelle
    van Laar, Teus
    Storch, Alexander
    Micheli, Federico
    Burn, David
    Durif, Frank
    Pahwa, Rajesh
    Callegari, Francesca
    Tenenbaum, Nadia
    Strohmaier, Christine
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (01) : 9 - 16
  • [34] Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
    Uchio, Yuji
    Enomoto, Hiroyuki
    Ishida, Mitsuhiro
    Tsuji, Toshinaga
    Ochiais, Toshimitsu
    Konno, Shinichi
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 1391 - 1403
  • [35] A long-term, open-label extension study to investigate the long-term safety of alogliptin in subjects with type 2 diabetes
    Smith, N.
    Pratley, R.
    Wilson, C.
    Mekki, Q.
    DIABETOLOGIA, 2017, 60 : S357 - S358
  • [36] Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
    Saleh, Mansoor N.
    Bussel, James B.
    Cheng, Gregory
    Meyer, Oliver
    Bailey, Christine K.
    Arning, Michael
    Brainsky, Andres
    BLOOD, 2013, 121 (03) : 537 - 545
  • [37] An open-label study to evaluate the long-term safety of zelrix™, a sumatriptan iontophoretic patch for the treatment of acute migraine
    Smith, T.
    Pierce, M.
    Griesser, J.
    Sebree, T.
    O'Neill, C.
    CEPHALALGIA, 2011, 31 (01) : 120 - 120
  • [38] Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents
    Berenson, Frank
    Vasconcellos, Elza
    Pakalnis, Ann
    Mao, Lian
    Biondi, David M.
    Armstrong, Robert B.
    HEADACHE, 2010, 50 (05): : 795 - 807
  • [39] ADHD treatment with once-daily OROS® MPH:: A long-term, open-label study of safety and tolerability
    Wolraich, ML
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [40] Efficacy and safety of long-term, open-label treatment with calcitriol in postmenopausal osteoporosis: A retrospective analysis
    Caniggia, A
    Nuti, R
    Martini, G
    Frediani, B
    Giovani, S
    Valenti, R
    Silvestri, G
    Matarazzo, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (11): : 857 - 868
12345